Molecular Diagnostics Market will be a new dimension in the upcoming years 2019-2027

Molecular diagnostics includes various techniques to analyze biological markers in the genome and proteome. These techniques are used to guide patient's right from diagnosis to treatment, for diseases like cancer, infectious disease, and congenital abnormalities. These techniques help in identifying the genetic variants that have led to the disease. Molecular diagnostic procedures that are routinely used include polymerase chain reaction (PCR), real-time PCR, restriction fragment length polymorphism analysis (RFLP), fluorescence in situ hybridization, gel electrophoresis, single-stranded conformation polymorphism, hybrid capture, and other assays.

The molecular diagnostics market is anticipated to grow in the forecast period owing to key factors such as increasing prevalence of infectious diseases and different types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market and advancements in molecular techniques. However, technical issues related to sample collection and storage and risk of contamination and complex regulatory scenario hampers growth of this market.

 

Download Sample Copy of " Molecular Diagnostics Market " Report @  https://www.premiummarketinsights.com/sample/TIP00009334

Some of the key players operating in the molecular diagnostics market include, Abbott, Agilent Technologies, Inc, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN, bioM?rieux SA, BD, Illumina, Inc., and Danaher among others.

The "Global Molecular Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global molecular diagnostics market with detailed market segmentation by product, technology, application, end user and geography. The global molecular diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading molecular diagnostics market players and offers key trends and opportunities in the market.

The global molecular diagnostics market is segmented on the basis of product, technology, application, and end user. Based on product, the molecular diagnostics market is segmented as reagents & kits, instruments, software and services. Based on technology, the molecular diagnostics market is segmented polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing & next-generation sequencing (NGS), in situ hybridization, DNA microarray, other technologies. On the basis of application the molecular diagnostics market is segmented as infectious diseases, oncology, genetic tests, other. The end user segment consists of hospital & academic laboratories reference laboratories and other.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Molecular diagnostics market based on product, technology application and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The molecular diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the molecular diagnostics market in the forecast period, due to growing prevalence of infectious diseases and cancers, presence of large number of well-established market players in the U.S., sophisticated healthcare structure and growing aging population are likely to influence the growth of the molecular diagnostics market. However, Asia Pacific region is expected to be the fastest growing region owing to increasing prevalence of chronic diseases and growing focus on development of better diagnostic procedures.

The report analyzes factors affecting molecular diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the molecular diagnostics market in these regions.

Purchase this report @  https://www.premiummarketinsights.com/buy/TIP00009334

Table of Contents 

1. INTRODUCTION
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. MOLECULAR DIAGNOSTICS MARKET LANDSCAPE
5. MOLECULAR DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
6. MOLECULAR DIAGNOSTICS MARKET- GLOBAL ANALYSIS
7. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
8. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
9. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
10. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - END USER
11. MOLECULAR DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12. INDUSTRY LANDSCAPE
13. MOLECULAR DIAGNOSTICS MARKET, KEY COMPANY PROFILES

About us:

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.

We provide best in classcustomer service and our customer support team is always available to
help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

 

Contact us:
Premium Market Insights,
Contact Person: Sameer Joshi
Email: [email protected]

Posted by on Tuesday March 26 2019, 2:48 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in